![Peter Powchik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Powchik
Keine laufenden Positionen mehr
Profil
Peter Powchik's former jobs include being a Senior Medical Director at Sumitomo Pharma America, Inc., a Principal at Pfizer Inc., a VP-Clinical Development & Medical Affairs at Novartis Pharmaceuticals Corp., a Chief Medical Officer & Senior Vice President at Chugai Pharma USA LLC, and a Senior Vice President-Clinical Development at Regeneron Pharmaceuticals, Inc. He also served as the Global Scientific Director, Director & EVP at Vaxxinity, Inc. from 2023 to 2024.
Dr. Powchik obtained a doctorate degree from New York University School of Medicine.
Ehemalige bekannte Positionen von Peter Powchik
| Unternehmen | Position | Ende |
|---|---|---|
| VAXXINITY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2024 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2018 |
Chugai Pharma USA LLC
 Chugai Pharma USA LLC Medical DistributorsDistribution Services Develops safe and effective drugs | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2006 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2005 |
| PFIZER INC. | Corporate Officer/Principal | 01.04.2001 |
Ausbildung von Peter Powchik
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
82
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Develops safe and effective drugs | Distribution Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxxinity, Inc.
 Vaxxinity, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops prophylactic and therapeutic vaccines | Health Technology |
Chugai Pharma USA, Inc.
 Chugai Pharma USA, Inc. Aerospace & DefenseElectronic Technology The private company is based in Berkeley Heights, NJ. The company supports the planning and execution of clinical development programs for drug candidates originating from Chugai, focusing on areas with serious unmet medical needs such as oncology and autoimmune diseases. It plays a key role in early clinical development, regulatory affairs, quality assurance, and business strategy to advance therapies from preclinical research through proof of concept. The company engages with patient communities and advocacy groups to incorporate their perspectives into drug development and corporate strategy. Its regulatory affairs team ensures compliant submissions for patient access, and the quality assurance department adheres to good clinical practice and process improvements. Chugai Pharma USA, Inc. was founded in 2008. | Electronic Technology |
